Find a Doctor or Practice Location

Are you a referring physician?
within
I am searching for a
Reset Form
Paco Eduardo Bravo, MD

Paco Eduardo Bravo, MD Physician

Director of Nuclear Cardiology and Cardiovascular Imaging Clinical Associate of Radiology Assistant Professor of Radiology at the Hospital of the University of Pennsylvania Assistant Professor of Medicine

Dr. Bravo is employed by Penn Medicine.

Clinical Specialties

Specialty:

  • Radiology

Programs & Centers:

Board Certification:

  • Cardiovascular Disease, 2015
  • Internal Medicine, 2008
  • Nuclear Medicine, 2010

Description of Clinical Expertise

Cardiac PET, myocardial blood flow quantification in ischemic and non-ischemic heart disease, myocardial inflammation, myocardial viability, cardiac magnetic resonance imaging, cardiomyopathies.

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Amerihealth
  • NJ Medicaid
  • NJ Medicare
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Care
  • Preferred Health Care/LGH
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Vetrans Choice Program (6/2018 Not Active)

Education and Training

Medical School:
Residency: University of Alabama Hospital
Residency: Johns Hopkins Hospital
Fellowship: University of Washington Hospital and Clinics

Memberships

American Society of Nuclear Cardiology (ASNC), National Radiological Society of North America (RSNA), National Society of Nuclear Medicine and Molecular Imaging (SNMMI), National

Hospital Affiliation

Dr. Bravo is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

I have a particular interest in the complementary role of radionuclide molecular imaging techniques and tissue characterization with contrast-enhanced cardiac magnetic resonance imaging for sub-clinical detection, phenotyping, diagnosis, and risk stratification of individuals with various forms of cardiomyopathy.

Selected Publications:

Bravo PE, Vita TS, Taqueti V, Veillet-Chowdhury M, Steigner M, Skali H, Dorbala S, Di Carli MF, Blankstein R.: Detection of Myocardial Inflammation by T2-weighted Imaging on Cardiac MRI versus FDG PET Among Patients with Suspected Cardiac Sarcoidosis. ASNC,22nd Annual Scientific Session : 2017.

Bravo PE, Fujijura K, Kijewski MF, Jacob S, Sticka W, Dubey S, Belanger A, Park M, Di Carli MF, Falk RH, Dorbala S.: Apical Sparing of Longitudinal Strain Cannot be Explained by Regional Differences in Florbetapir Retention in Cardiac Amyloidosis. ASNC, 22nd Annual Scientific Session. ASNC, 22nd Annual Scientific Session : 2017.

Bravo PE, Raghu G, Rosenthal DG, Elman S, Petek BJ, Soine LA, Maki JH, Branch KR, Masri SC, Patton KK, Caldwell JH, Krieger EV.: Risk assessment of patients with clinical manifestations of cardiac sarcoidosis with positron emission tomography and magnetic resonance imaging. Int J Cardiol. 15 (241): 457-462,2017.

Gupta A, Taqueti VR, van de Hoef TP, Bajaj NS, Bravo PE, Murthy VL, Osborne MT, Seidelmann SB, Vita TS, Bibbo CF, Harrington M, Hainer J, Rimoldi O, Dorbala S, Bhatt DL, Blankstein R, Camici PG, Di Carli MF.: Integrated Non-invasive Physiological Assessment of Coronary Circulatory Function and Impact on Cardiovascular Mortality in Patients with Stable Coronary Artery Disease. Circulation. : 2017.

Bravo PE, Di Carli MF, Dorbala S: Role of PET to evaluate coronary microvascular dysfunction in non-ischemic cardiomyopathies Heart Fail Rev 22 (4): 455-464,2017.

Bravo PE, Dorbala S.: Targeted Nuclear Imaging Probes for Cardiac Amyloidosis. Curr Cardiol Rep 19 (7): 59,2017.

Bravo PE, Taqueti VR.: Cardiac MRI vs. PET for the Evaluation of Cardiac Sarcoidosis: Consider MRI First. Consider MRI First. http://www.acc.org : 2017.

Bravo PE, Tahari A, Pozios I, Luo HC, Bengel FM, Wahl RL, Abraham MR, Abraham TP.: Apparent Left Ventricular Cavity Dilatation during PET/CT in Hypertrophic Cardiomyopathy: Clinical Predictors and Potential Mechanisms. J Nucl Cardiol. 23 (6): 1304-1314,2016.

Seidelmann SB, Claggett B, Bravo PE, Gupta A, Farhad H, Klein BE, Klein, R, Di Carli MF, Solomon SD.: Retinal Vessel Calibers in Predicting Longterm Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study. Circulation. 134 (18): 1328-1338,2016.

Okada DR, Bravo PE, Vita T, Agarwal V, Osborne MT, Taqueti V, Skali H, Chareonthaitawee P, Dorbala S, Stewart G, Di Carli M, Blankstein R.: Isolated cardiac sarcoidosis: A focused review of an under-recognized entity. J Nucl Cardiol. J Nucl Cardiol : 2016.

Academic Contact Info

Hospital of the University of Pennsylvania
3400 Civic Center Boulevard
11-154 South Pavilion

Philadelphia, PA 19104
Phone: (215) 220-9494